Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Explore this article's sources with AI

ChatGPTClaudePerplexityGeminiGrokGoogle AI

Follow PeptideMethods on Google

First published

TB-500 import rules in Denmark

Denmark's 2026 private-import rules are conditional, and TB-500 has no routine authorised Danish pack. Here is the source-bounded answer.

Why we wrote this. Danish readers need the current private-import conditions without customs workarounds or unsupported claims of blanket legality.

In this article (6 sections)
  1. The Danish rule that applies from 2026
  2. Why TB-500 needs a product-level check
  3. What customs can look for
  4. The anti-doping issue is separate
  5. What not to rely on
  6. A defensible answer for Danish readers

Denmark's private-import rules do not create a simple permission to order TB-500 online. From 1 January 2026, ordinary medicine for personal use may be brought into Denmark or received by post only when it was legally purchased in the country of sale and the buyer can document personal use. Separate, stricter rules apply when a product is treated as a doping agent: import requires a prescription, and receipt by mail from outside the EU or EEA is not allowed.[1][2]

TB-500 is not named on the Danish Medicines Agency import page, so this article does not pretend that every parcel receives one automatic classification. The safe answer is product-specific. A TB-500-labelled vial sold for recovery may be treated as a medicine, while its connection to thymosin beta-4 and the international anti-doping list creates a separate reason to ask whether Denmark's doping rules apply. A seller's research-use label does not answer either question.

The Danish rule that applies from 2026

The Danish Medicines Agency says that private individuals may import ordinary medicine for personal use when the medicine was purchased legally in the country where it was sold and personal use can be documented. The agency's table covers carriage and mail from EU or EEA and non-EU or EEA countries. It then sets different conditions for antibiotics, narcotic substances and doping products.[1]

For doping products, the table says carriage or mail from the EU or EEA requires a prescription. Carriage from outside the EU or EEA also requires a prescription and is limited to three months, while mail from outside the EU or EEA is marked no. The underlying statutory order is Order no. 1523 of 3 December 2025 on private individuals' import of medicines for humans and animals.[1][2]

Those rules are conditions, not guarantees. They do not make an unauthorised product lawful in its country of sale, prove that a prescription covers the exact product, or establish that the contents match the label. They also do not grant a Danish marketing authorisation. Import, marketing, prescribing and possession are separate legal questions.

Why TB-500 needs a product-level check

TB-500 is a name used for a peptide associated with thymosin beta-4. Online listings are inconsistent about whether the vial contains a short fragment or full-length thymosin beta-4. That distinction matters because Danish authorities assess the actual product, its composition, presentation and intended use. A label promising tendon repair or faster recovery can support treatment as a medicine even when the same page says research use only.

We found no routine Danish product-summary or official price listing for TB-500 in the Danish Medicines Agency portals checked on 4 November 2026. Produktresumé.dk is the agency's official product-summary portal, while Medicinpriser.dk lists registered medicines, prices and reimbursement information.[3][4]

An absence result is narrower than a ban. It means we could not identify an authorised Danish TB-500 pack that a traveller or buyer could point to as a routine Danish medicine. It does not decide every clinician-led special-supply question, customs assessment or enforcement case. The exact manufacturer, formulation, source country and documentation still matter.

What customs can look for

The agency says a person must be able to document that imported medicine is for personal use. It gives examples such as a prescription or a receipt. It also requires lawful purchase in the country of sale. Those points make the sender, product identity, quantity, invoice and prescription relevant when a parcel is assessed.[1]

A vial labelled TB-500 but accompanied only by a vendor invoice does not thereby satisfy the rule. The invoice may show payment but not lawful sale, medicinal identity, prescription coverage or personal clinical use. Mismatched names, unclear strength, bulk quantities or claims that contradict a research-only label can add uncertainty. We found no official Danish checklist saying that any one feature automatically triggers seizure.

Customs clearance is not approval. Some parcels may not be inspected, but passing the border does not establish lawful sale or quality. Conversely, detention does not by itself prove a criminal offence. Authorities may hold a shipment while the product and documents are assessed. A recipient should use the contact details on an official notice rather than trying another route or changing the declaration.

The anti-doping issue is separate

USADA's official summary of the 2018 WADA list states that thymosin beta-4 and its derivatives, including TB-500, were added under section S2.3. That sports prohibition is not the same thing as Danish medicines law, but it is relevant to athletes and to the Danish import page's separate doping category.[5]

This article does not infer from the WADA list alone that every TB-500-labelled item will automatically receive the Danish legal classification of a doping agent. WADA rules govern sport, while Danish import law is applied by Danish authorities. A tested athlete should nevertheless treat TB-500 as prohibited in and out of competition and seek advice from Anti Doping Denmark about sport-specific consequences.

What not to rely on

Do not rely on a seller's claim that small quantities are allowed, that customs rarely checks peptides, or that a research label avoids medicine rules. None of those statements appears in the Danish Medicines Agency guidance. Do not split an order, misdescribe the contents or use a different route to avoid inspection. This page does not provide workarounds.

A foreign prescription is also not a universal answer. The official rule makes a prescription a condition for doping imports in specified routes, but the product must still have been legally purchased and the documentation must fit the actual item and personal use. A prescription cannot authenticate an unidentified vial or convert an unlawful foreign sale into a lawful one.

The distinction between carrying medicine and receiving it by mail also matters. The official table treats those routes separately, especially for products in the doping category. Advice about medicine carried during travel should not be copied onto a courier order. Likewise, an EU return address does not prove that a product was legally sold in the dispatch country or originated there. The agency's conditions focus on the medicine and transaction, not only the address printed on a parcel. If the seller will not identify the legal product, responsible pharmacy or source-country status, the buyer lacks the facts needed for a reliable import assessment.

A defensible answer for Danish readers

Direct mail of a product treated as doping from outside the EU or EEA is not permitted under the agency's current table. Other routes are conditional, and TB-500 has no routine authorised Danish pack that we could identify. That combination means a direct online order cannot be described as clearly lawful. The responsible next step is to ask the Danish Medicines Agency about the exact product before money or a parcel changes hands.

For the wider framework, read our Denmark regulation hub and TB-500 evidence overview. A licensed clinician can discuss authorised options for the condition behind the search. Neither page recommends obtaining TB-500.

Medical disclaimer: This article is for educational and journalistic purposes only and does not constitute medical advice. Peptides discussed may be classified as prescription medicines or research chemicals depending on your jurisdiction. Always consult a qualified healthcare professional before using any peptide product. PeptideMethods.com does not sell, distribute, or facilitate the sale of any peptide product.

Regulatory disclaimer: This page reflects our understanding of the regulatory status as of 2026-11-04. Regulations change. Verify with the official regulator before making any decision. PeptideMethods.com is not a law firm and does not provide legal advice.

Frequently asked

Can TB-500 be mailed to Denmark for personal use?

There is no blanket permission. Ordinary medicine must be legally purchased and documented for personal use. If the product is treated as doping, mail from outside the EU or EEA is not allowed, while EU or EEA mail requires a prescription.

Is TB-500 an authorised Danish medicine?

No routine Danish TB-500 product summary or official price listing was identified in the Danish Medicines Agency portals checked on 4 November 2026. That is an absence finding, not a ruling on every possible case.

What documents can Denmark require?

The Danish Medicines Agency says personal use must be documented and gives a prescription or receipt as examples. The product must also have been legally purchased in the country of sale.

Does a research-use label make import lawful?

No. A seller's label does not determine Danish classification, prove lawful sale, establish medicinal identity or satisfy prescription conditions. Authorities can assess the product, presentation and intended use.

Is TB-500 prohibited in sport?

Yes. The official USADA summary records thymosin beta-4 and its derivatives, including TB-500, under WADA section S2.3. Sports rules are separate from Danish import law.

Sources

  1. [1]Danish Medicines Agency: How to import medicine into Denmark from 1 January 2026Tier 1 · primary↩
  2. [2]Retsinformation: Order no. 1523 of 3 December 2025 on private medicine importsTier 1 · primary↩
  3. [3]Danish Medicines Agency: official product-summary searchTier 1 · primary↩
  4. [4]Danish Medicines Agency: official medicine price and reimbursement databaseTier 1 · primary↩
  5. [5]USADA: 2018 Prohibited List changes naming thymosin beta-4 and TB-500Tier 1 · primary↩

No revisions yet. First published .

About the editorial team

PeptideMethods is written and edited by the PeptideMethods Editorial Team and published by Digital Compass Group Ltd. The team is not made up of medical professionals; every health, regulatory or dosage claim on the site is tied to a primary source and is not a substitute for advice from a qualified clinician.

See our editorial policy and methodology for how we research, source and verify.

Read the pillars